Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ta Deng"'
Autor:
David E Kerr, George Shen, Andrew H Lienau, Ta Deng, Mandeep Kaur, Amy L Immermann, Philip T Feldsine, Lisa John, Yi Chen, Michael Brodsky, Wayne Ziemer
Publikováno v:
Journal of AOAC INTERNATIONAL. 102:828-841
TRANSIA® PLATE Salmonella Gold is an ELISA that was validated by Association Française de Normalisation (AFNOR) in 2001 and as a Performance Tested MethodSM (PTM) by AOAC in 2006 (PTM No. 010602) as a two-step enrichment protocol requiring 48 h. A
Autor:
David E, Kerr, George, Shen, Andrew H, Lienau, Ta, Deng, Mandeep, Kaur, Amy L, Immermann, Philip T, Feldsine, Lisa, John, Yi, Chen, Michael, Brodsky, Wayne, Ziemer
Publikováno v:
Journal of AOAC International. 102(3)
TRANSIA
Autor:
Susan Brophy, Xiaochun Qin, Rebecca L. Rich, Mary M. Murphy, Hann-Wen Guan, Nenad Tomasevic, Tanya Hayden, Giuseppe A. Papalia, Stephanie Leavitt, Brad Condon, Ta Deng, Fabio Parmeggiani, Thomas Heutmekers, Daniel Bedinger, Terry Nakagawa, Iva Navratilova, Tiffany Tsang, Bart Hoorelbeke, David G. Myszka, M. Brett Waddell, Fred Feiyu Zhang, Sabina Rebe, Mark C. McCroskey, Anne W Emerick
Publikováno v:
Analytical Biochemistry, 364(1), 67-77
Analytical Biochemistry 364 (2007) 1
Analytical Biochemistry 364 (2007) 1
A total of 22 individuals participated in this benchmark study to characterize the thermodynamics of small-molecule inhibitor–enzyme interactions using Biacore instruments. Participants were provided with reagents (the enzyme carbonic anhydrase II,
Autor:
Michael L. Linenberger, Richard Ingber, Jennifer L. Rohn, Ta Deng, Stephanie Ellis-Smith, Julie Overbaugh
Publikováno v:
Veterinary Immunology and Immunopathology. 70:223-243
Tumorigenesis occurs through a multistep process initiated by genetic lesions and facilitated by endogenous and external growth/survival signals. In many malignancies, specific oncogenic mutations correlate with phenotypic characteristics, inferring
Publikováno v:
Biochemistry. 40(6)
A novel serine protease was found in human prostate by degenerate oligonucleotide PCR amplification and cloned. The zymogen form of this enzyme, named prostinogen, is composed of 240 amino acid residues with an amino-terminal propiece of 5 residues a
Autor:
Michael L. Linenberger, Ta Deng
Publikováno v:
Veterinary immunology and immunopathology. 72(3-4)
To identify potential roles of cytokines in retroviral pathogenesis, we used reverse transcription-quantitative competitive polymerase chain reaction (RT-qcPCR) assays to characterize mRNA levels of 19 different lymphokines, chemokines, monokines and
Autor:
Daniel A. Holterman, Shannon E. Smith, David Spetzler, Ta Deng, Janet E. Duncan, Christine Kuslich
Publikováno v:
Cancer Research. 71:1568-1568
Circulating microvesicles (cMV) are membrane-bound structures that play an important role in several biologic processes, including angiogenesis and immune modulation. cMV levels are known to change in response to certain pathologies, and specific sub
Autor:
Tanya H. Little, Daniel A. Holterman, Katrina Radebach, David Spetzler, Ta Deng, Traci Pawlowski, Shannon E. Smith, Janet E. Duncan, Christine Kuslich
Publikováno v:
Cancer Research. 71:444-444
The purpose of this study was to determine if circulating microvesicle (cMV) subpopulations as defined by surface protein composition also exhibit distinct microRNA (miR) expression patterns. Circulating microvesicles isolated from a prostate cancer
Autor:
David Spetzler, Phil Ellis, Teresa L. Tinder, Jeff Kimbrough, Daniel A. Holterman, Todd Maney, Ta Deng, Christine Kuslich
Publikováno v:
Cancer Research. 71:4060-4060
Endothelial- and leukocyte-derived circulating microvesicles (cMV) represent a majority of the cMV present in the blood. The purpose of this study was to determine if depletion of these more common cMV populations is possible, allowing for the enrich
Autor:
Traci Pawlowski, Christine D. Kuslich, Teresa L. Tinder, Jeff Kimbrough, Ta Deng, David Spetzler, Joon Kim
Publikováno v:
Cancer Research. 70:821-821
We have developed a novel, versatile, multiplexed exosome-based diagnostic platform that can identify highly specific and sensitive disease biosignatures. This platform has been used to identify a plasma-based exosome biosignature for prostate cancer